PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Cerebral and tissue oximeters: Analysis of approved products
• Description about some key devices
PART 06: Cost and benefit analysis of cerebral and tissue oximeters
• Cost and benefit analysis of INVOUS tissue oximeter
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Geographical segmentation
• Cerebral and tissue oximetry devices market in Americas
• Cerebral and tissue oximetry devices market in EMEA
• Cerebral and tissue oximetry devices market in APAC
PART 09: Market drivers
• Incidence of cerebral hypoxia
• Incorporation of near-infrared spectroscopy
• Monitoring intraventricular hemorrhage
PART 10: Impact of drivers
PART 11: Market challenges
• Limitations of available cerebral oximeters
• Stringent regulatory framework
• Unfavorable reimbursement scenario
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Development of multi-parameter oximeters
• Product approvals
• Distribution agreements
PART 14: Vendor landscape
• Competitive scenario
• Key vendors
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
PART 16: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key 510(k) FDA-approved cerebral and tissue oximeters
Exhibit 03: Cost savings for cardiac surgeries that involved INVOUS tissue oximeter
Exhibit 04: Global cerebral and tissue oximetry devices market 2015-2020 ($ millions)
Exhibit 05: Five forces analysis
Exhibit 06: Global cerebral and tissue oximetry devices market segmentation by geography 2015
Exhibit 07: Global cerebral and tissue oximetry devices market segmentation by geography 2020
Exhibit 08: Global cerebral and tissue oximetry devices market segmentation by geography 2015-2020
Exhibit 09: Global cerebral and tissue oximetry devices market segmentation by geography 2015-2020 ($ millions)
Exhibit 10: Cerebral and tissue oximetry devices market in Americas 2015-2020 ($ millions)
Exhibit 11: Cerebral and tissue oximetry devices market in EMEA 2015-2020 ($ millions)
Exhibit 12: Cerebral and tissue oximetry devices market in APAC 2015-2020 ($ millions)
Exhibit 13: Impact of drivers
Exhibit 14: Impact of drivers and challenges
Exhibit 15: CAS Medical Systems: Business segmentation by revenue 2014
Exhibit 16: CAS Medical Systems: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 17: CAS Medical Systems: Revenue of tissue oximetry monitoring segment 2014
Exhibit 18: CAS Medical Systems: Revenue of tissue oximetry monitoring segment by region 2014
Exhibit 19: CAS Medical Systems: Geographical segmentation by revenue 2014
Exhibit 20: CAS Medical Systems: Key takeaways
Exhibit 21: Masimo: Business segmentation by revenue 2016
Exhibit 22: Masimo: Business segmentation by revenue 2015 and 2016 ($ millions)
Exhibit 23: Masimo: Key takeaways
Exhibit 24: Medtronic: Product offerings
Exhibit 25: Medtronic: Key takeaways
Exhibit 26: Nonin Medical: Key takeaways
Exhibit 27: Other prominent vendors
【掲載企業】
CAS Medical Systems Inc., Masimo Corp., Medtronic plc, Nonin Medical Inc, Hamamatsu Photonics, Hutchinson Technology, HyperMed, ISS, Moor Instruments, Ornim Medical, Reflectance Medical, Spectros, ViOptix.
【資料のキーワード】
脳、脳組織、酸素測定機器、医療デバイス
【調査方法】
一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)
【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。